Assenagon Asset Management
XLRN

Assenagon Asset Management’s Acceleron Pharma XLRN Stock Holding History

Assenagon Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-476,423
Closed -$82M – 1616
2021
Q3 		$82M Sell
476,423
-97,379
-17% -$12.7M 0.26% 72
2021
Q2 		$72M Buy
573,802
+439,489
+327% +$55.4M 0.24% 76
2021
Q1 		$18.2M Buy
134,313
+33,977
+34% +$4.39M 0.07% 223
2020
Q4 		$12.8M Buy
100,336
+86,714
+637% +$10.2M 0.06% 213
2020
Q3 		$1.53M Buy
13,622
+8,733
+179% +$869K 0.01% 649
2020
Q2 		$466K Buy
+4,889
New +$471K ﹤0.01% 976

Assenagon Asset Management's XLRN Position: Q4 2021 in Review

Assenagon Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 476,423 shares — an estimated $82M sold.

Assenagon Asset Management first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $82M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Assenagon Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 476,423 Acceleron Pharma shares in Q4 2021, an estimated $82M.
  • Assenagon Asset Management first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
  • Assenagon Asset Management's Acceleron Pharma position peaked at $82M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Assenagon Asset Management's 13F filing for Q4 2021, filed 1 Feb 2022.